n-acetyl-demethylmuramyl-alanyl-isoglutamine has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogura, T; Okubo, A; Sone, S; Tanaka, M | 1 |
| Sone, S; Utsugi, T | 1 |
2 other study(ies) available for n-acetyl-demethylmuramyl-alanyl-isoglutamine and Melanoma
| Article | Year |
|---|---|
Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Cell Communication; Cell Line; Cell Membrane; Colonic Neoplasms; Cytotoxicity Tests, Immunologic; Formaldehyde; Humans; Idoxuridine; Interferon Type I; Interferon-gamma; Interferons; Interleukin-1; Kinetics; Leukocytes, Mononuclear; Melanoma; Polymers; Recombinant Proteins | 1989 |
Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Cytotoxicity, Immunologic; Drug Synergism; Humans; Interferon Type I; Interferon-gamma; Killer Cells, Natural; Leukopenia; Macrophage Activation; Melanoma; Monocytes; Polymyxin B; Recombinant Proteins; Time Factors | 1986 |